Home LiteratureArticle Details
PMID: 7356678 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.

The Journal of clinical investigation ·Vol. 65 ·No. 2 ·1980-02-00 ·Pages 268-76

Merrill WW, Naegel GP, Matthay RA, Reynolds HY

Abstract

Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a mechanism by which these cells, after phagocytic challenge, may control or amplify the inflammatory response in lung parenchyma. Normal human alveolar macrophages (AM) were studied from eight subjects. With in vitro culture, AM produced and released two substances into culture media which have potent chemoattractant activity for blood polymorphonuclear granulocytes (PMN) and negligible activity for mononuclear cells. Release of these factors is maximally stimulated by aggregated human immunoglobulin (Ig)G or zymosan particles; however, simple adhesion of the macrophages to plastic surfaces is also sufficient to stimulate release of these chemotactic substances. The larger substance (10,000 daltons) is immunologically distinct from C5a and interacts with a different PMN membrane receptor than that known to exist for formyl-methionyl-leucyl-phenylalanine. Its chemotactic activity is sensitive to the enzymatic effect of trypsin. Although producing a single elution peak on gelfiltration chromatography, electrofocusing in polyacrylamide gels yielded five peaks of radioactivity. Chemotactic activity was localized to a fraction with a pI = 5.0. The smaller molecular weight substance has been less well characterized. Thus, the human AM can produce at least two factors which attract PMN and this capability may augment the local inflammatory response in the lung.

MeSH Terms
Cells, Cultured Chemotactic Factors/biosynthesis,pharmacology Female Granulocytes/drug effects Humans Immunoglobulin G/administration & dosage In Vitro Techniques Kinetics Leukocytes/drug effects Macrophages/metabolism Male Molecular Weight Pulmonary Alveoli/metabolism Smoking/physiopathology Zymosan/pharmacology
Chemicals
Chemotactic Factors Immunoglobulin G Zymosan
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Merrill W W
Naegel G P
Matthay R A
Reynolds H Y
References (27)
27 references, click to expand
  1. Chemotactic factor inactivators of human granulocytes.
    J Clin Invest. 1977 Dec;60(6):1280-8 PMID: 334799
  2. Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes.
    J Exp Med. 1974 May 1;139(5):1175-88 PMID: 4132993
  3. Determination of cell viability.
    Proc Soc Exp Biol Med. 1958 May;98(1):188-92 PMID: 13554587
  4. Structural composition of canine secretory component and immunoglobulin A.
    Biochemistry. 1975 Jul;14(13):2853-60 PMID: 807240
  5. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.
    Clin Immunol Immunopathol. 1975 Jan;3(3):334-46 PMID: 1088938
  6. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
    J Clin Invest. 1975 Aug;56(2):376-85 PMID: 807599
  7. Secretory function of mononuclear phagocytes: a review.
    Am J Pathol. 1976 May;83(2):396-418 PMID: 178186
  8. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.
    J Clin Invest. 1977 Jan;59(1):179-83 PMID: 830662
  9. Lung host defenses: a status report.
    Chest. 1979 Feb;75(2 Suppl):239-42 PMID: 582028
  10. Measurement of chemotaxis of human polymorphonuclear leukocytes in filters by counting the number of cells in a single plane and comparison with leading front method.
    J Immunol Methods. 1976;13(2):191-7 PMID: 789778
  11. THE PARTICULATE HYDROLASES OF MACROPHAGES. II. BIOCHEMICAL AND MORPHOLOGICAL RESPONSE TO PARTICLE INGESTION.
    J Exp Med. 1963 Dec 1;118:1009-20 PMID: 14112262
  12. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
    Scand J Clin Lab Invest Suppl. 1968;97:77-89 PMID: 4179068
  13. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
    J Exp Med. 1976 May 1;143(5):1154-69 PMID: 1262785
  14. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    J Clin Invest. 1977 Feb;59(2):273-81 PMID: 401834
  15. THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.
    J Exp Med. 1964 Jan 1;119:167-76 PMID: 14113111
  16. Preparation of iodine-131 labelled human growth hormone of high specific activity.
    Nature. 1962 May 5;194:495-6 PMID: 14450081
  17. Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist.
    J Immunol. 1978 Apr;120(4):1326-32 PMID: 641351
  18. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages.
    Am Rev Respir Dis. 1978 Jan;117(1):15-23 PMID: 619716
  19. The macrophage receptor for IgG: number and affinity of binding sites.
    J Immunol. 1973 Jun;110(6):1455-63 PMID: 4712920
  20. Biologic activity of aggregated gamma-globulin. II. A study of various methods for aggregation and species differences.
    J Immunol. 1960 Aug;85:163-71 PMID: 13718021
  21. Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.
    J Clin Invest. 1974 Sep;54(3):519-28 PMID: 4853956
  22. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
    J Clin Invest. 1977 May;59(5):951-8 PMID: 140184
  23. Defense mechanisms of the respiratory membrane.
    Am Rev Respir Dis. 1977 Mar;115(3):479-514 PMID: 320925
  24. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
    J Exp Med. 1973 Feb 1;137(2):387-410 PMID: 4568301
  25. The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics.
    J Clin Invest. 1971 Jul;50(7):1390-8 PMID: 4996883
  26. The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism.
    Lipids. 1979 Feb;14(2):181-93 PMID: 106197
  27. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.
    J Lab Clin Med. 1974 Oct;84(4):559-73 PMID: 4412011
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1980-02-00
Pages
268-76
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC371363
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com